Skip to content
Search AI Powered

Latest Stories

Community pharmacies surpass 40m Covid-19 vaccinations milestone

Community pharmacies surpass 40m Covid-19 vaccinations milestone

The CCA believes that community pharmacy can eventually become the “natural home for all vaccinations.”

A quarter of all Covid-19 vaccines administered to date in England were delivered by community pharmacies, the Company Chemist Association (CCA) has revealed citing Freedom of Information (FoI) data from NHS England.


Overall, the sector had administered 40,045,279 Covid-19 vaccines by the end of 2023, with 62 per cent of all vaccines administered in community pharmacies in December 2023.

According to the association, the data “reaffirms the ever-growing role pharmacy is playing in the Covid-19 vaccination programme.”

The CCA has calculated that pharmacies could administer an additional 10 million vaccination appointments per year.

Malcolm Harrison, Chief Executive of the CCA said: “Administering over 40m Covid-19 vaccines, a quarter of all vaccines to date, is a truly fantastic achievement by the sector. This is despite community pharmacy initially not being considered a major part of the programme.

This is further evidence of the track record pharmacies have in administering national vaccination programmes.”

Harrison added that community pharmacies can eventually become the “natural home for all vaccinations.”

The CCA has urged policymakers to explore the sector’s enhanced role and to design vaccination programme considering the needs of pharmacy businesses.

It highlighted the importance of integrating the National Booking System into existing pharmacy systems, reviewing the fee in light on the continued increased cost of business, and simplifying the site designation process.

Commenting on the sector’s success in the delivery of the Covid-19 programmes, Dr James Davies, Director of RPS in England, said: "This is a fantastic achievement and a testament to the hard work and dedication of the thousands of community pharmacists and pharmacy teams across the country.

“Pharmacies are at the heart of communities and expanding vaccination services will play a key role in reducing health inequalities, in particular in deprived areas where trusted local pharmacists have proven they can help address vaccine hesitancy.

“With the right support and resources, pharmacists are ideally placed to expand vaccination coverage, engaging with their local communities to boost uptake and support public health and disease prevention."

Acknowledging community pharmacy’s role in vaccinations, NHS England recently announced its decision to extend the Covid-19 vaccination programme until 31 August 2024 and offered an additional payment of £2.50 per jab if pharmacies would be willing to join the spring booster programme.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less